Indap

Quick links to important sections

Indap

Selected form

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Indap

Indapamide is a prescription medication used primarily to treat high blood pressure (essential hypertension) and manage fluid retention (edema) that can occur with congestive heart failure. It is classified as a thiazide-like diuretic—often referred to informally as a "water pill"—which functions by increasing the kidneys' excretion of excess salt and water.


Quick Facts

Property Description
Active Ingredient (INN) Indapamide
Form Oral tablet (Immediate and Modified/Sustained-Release)
Pharmacological Class Thiazide-like Diuretic
Primary Use Essential Hypertension
Key Brands Natrilix, Lozol

Unique Properties and Cardiovascular Role

Indapamide is supported by clinical evidence for its dual mechanism of action. While its diuretic effect reduces fluid volume, the drug also exerts a direct, favorable action by relaxing the walls of blood vessels. This combination is recognized for its ability to lower blood pressure effectively while simultaneously reducing peripheral vascular resistance, which eases the workload on the heart.

This medication is commonly available in both standard immediate-release and modified/sustained-release (SR or XL) forms. The sustained-release version is designed to ensure a more consistent release of the active ingredient over 24 hours, which facilitates consistent blood pressure control with simple once-daily dosing. The long-term use of Indapamide has been consistently shown to help protect against major cardiovascular events, including stroke and heart attack.

What side effects are possible with Indap?

Possible Side Effects and Safety Information

The safety profile of Indapamide is characterized primarily by its effects on Metabolism and Nutrition and the Nervous System, as documented in official prescribing information. The most frequent safety concern is the potential for electrolyte disturbances, with hypokalemia (low potassium) classified as a common adverse reaction.


Official Frequency Classification

Classification Examples of Documented Adverse Reactions
Common ( ge 1/100 to < 1/10) Hypokalemia, Headache, Dizziness, Fatigue, Maculopapular rash
Uncommon ( ge 1/1,000 to < 1/100) Vomiting, Purpura
Rare ( ge 1/10,000 to < 1/1,000) Vertigo, Paresthesia, Renal failure
Very Rare ( < 1/10,000) Agranulocytosis, Angioedema, Stevens-Johnson Syndrome (SJS)
Not Known (Frequency cannot be estimated) Hyponatremia, Hepatic encephalopathy, Acute angle closure glaucoma

Serious Adverse Reactions and Restrictions

Officially documented serious adverse reactions include the risk of life-threatening cardiac arrhythmias, such as Torsades de Pointes, particularly when associated with severe hypokalemia. Severe cutaneous reactions (SJS and Toxic Epidermal Necrolysis) are also noted as very rare but critical concerns.

The medicine is subject to specific regulatory limitations, including its contraindication in patients with known hypersensitivity to sulfonamides, severe hepatic impairment, severe renal failure (anuria), and severe, persistent hypokalemia.

Safety notes specify that Orthostatic hypotension may be more noticeable at the start of treatment or following a dose increase. Additionally, individuals with pre-existing conditions like hepatic impairment or diabetes may require specific observation, as the drug can affect liver function and blood glucose control.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

The official overdose profile for this medication is structured around the consequences of exaggerated diuretic action, primarily profound fluid and electrolyte losses.

Overdose Scope

Domain Official Regulatory Statements
Documented Overdose Presentations Symptoms include vomiting, weakness, fatigue, lethargy, dizziness, dry mouth, thirst, muscle pains or cramps, and severe gastrointestinal disturbances. Physiological signs may include hypotension (low blood pressure) and tachycardia (fast heart rate).
Physiological Systems Affected Metabolic System (Severe Hypokalemia, Hyponatremia), Cardiovascular System (Circulatory Instability), Renal System (Oliguria/Anuria, Acute Renal Failure).
Serious Complications Officially documented severe outcomes include acute renal failure and the precipitation of hepatic encephalopathy (or coma) in patients with impaired hepatic function. The risk of potentially fatal Torsades de pointes is also associated with severe hypokalemia.
Emergency-Response Statements Regulatory documents explicitly state to seek immediate medical attention for any suspected overdose. The required management is symptomatic and supportive treatment, including the restoration of fluid and electrolyte balance. Decontamination procedures may involve gastric lavage and/or activated charcoal to eliminate unabsorbed drug.
When Immediate Medical Help is Required Immediate medical help is mandated for any symptoms that progress to profound hypotension, extreme drowsiness or confusion, collapse, or the appearance of hepatic encephalopathy.

Resulting Overdose Structure

Official overdose statements:

  • Overdose may present with hypotension, dizziness, drowsiness, and signs of severe electrolyte imbalance.
  • The regulator-mandated action is to seek immediate medical attention.
  • No specific antidote is known; management requires close monitoring of serum electrolytes and ECG to manage the risk of cardiac arrhythmias.

Connection to the overall overdose profile: Regulatory documents define the overdose profile by focusing on the physiological consequences of extreme fluid and mineral loss. The mandated emergency-seeking conditions are dictated by the documented risk of circulatory failure, CNS impairment, and severe metabolic disturbances that require specialized hospital monitoring to correct.

Therapeutic Uses of Indap

The therapeutic application of Indapamide is generally centered on supporting control over two key domains: sustained pressure management and symptoms related to systemic imbalance. It is commonly used to help with essential hypertension and fluid retention.

It is applied across domains where additional symptomatic support is needed, such as for managing essential hypertension, a condition involving sustained pressure elevation, and for easing symptoms related to physical discomfort like edema. The core long-term role contributes to easing the overall symptom load by supporting cardiovascular stability and addressing symptoms linked to organ-specific functional stress.

“The treatment is considered relevant when supportive symptom management is appropriate for specific populations, including older adults and patients with hypertension complicated by Type 2 Diabetes.”

This supportive effect contributes to improved day-to-day comfort during symptomatic periods by addressing symptoms that create noticeable physiological strain.


Quick Fact Block

Quick Fact: Relief for Sustained Pressure Quick Fact: Support for Fluid Balance
Addresses symptoms linked to heightened physiological activity and chronic pressure. Helps manage symptoms that interfere with daily functioning due to swelling.
The therapeutic role may assist with maintaining functional stability over time. Provides supportive relief when systemic or localized discomfort is present.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

The use of Indapamide is strictly defined by official regulatory criteria, focusing on absolute contraindications and population-specific restrictions. The medicine is primarily indicated for adults.

Absolute Prohibitions

Indapamide is contraindicated and must not be used by patients with a known hypersensitivity to the drug or to any sulfonamide-derived medicines. Use is also prohibited in individuals with Anuria (complete lack of urine production), severe hepatic impairment (including hepatic encephalopathy), or pre-existing hypokalaemia (low potassium levels). The medicine is also contraindicated in women who are breastfeeding.

Age and Conditional Use

Use is not recommended for children and adolescents (under 18 years) because safety and efficacy have not been established by regulatory authorities. While older adults are eligible, their use requires special caution and close monitoring of renal function and electrolytes. Use also requires conditional authorization and close monitoring for patients with moderate renal impairment, diabetes mellitus (due to effects on glucose tolerance), and conditions such as gout or hyperuricemia.

What should I know about interactions with other medicines?

Indapamide, a thiazide-like diuretic, has documented interactions that primarily relate to its effects on electrolytes, especially potassium, and its impact on blood pressure and cardiac rhythm.

Combinations to Avoid or Use with Extreme Caution

  • Lithium: Indapamide significantly reduces the kidney's ability to clear lithium, leading to elevated plasma lithium concentrations and a high risk of toxicity. Concomitant use is generally not recommended and requires close monitoring of lithium levels.
  • Medicines that Prolong the QT Interval: Due to the risk of Indapamide-induced hypokalemia (low potassium), the combination with medicines that can prolong the QTc interval (a measure of heart rhythm) increases the risk of severe cardiac arrhythmias, such as Torsades de Pointes. Examples include certain antiarrhythmics and antipsychotics.
  • Other Potassium-Depleting Agents: Co-administration with other diuretics or medicines that can cause hypokalemia (such as certain corticosteroids or stimulating laxatives) is not recommended, as it compounds the risk of dangerously low potassium levels.

Other Noteworthy Interactions

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): These can reduce the diuretic and antihypertensive effects of Indapamide. In certain situations, they may also increase the risk of hyperkalemia (high potassium) when combined with other blood pressure medicines.
  • Cardiac Glycosides (e.g., Digoxin): Indapamide-induced hypokalemia sensitizes the heart muscle to the effects of digoxin, increasing the risk of digitalis toxicity. Regular electrolyte monitoring is necessary.
  • Other Antihypertensive Agents: Concurrent use with other blood pressure-lowering medicines, including ACE inhibitors and calcium channel blockers, can have an additive or potentiating effect on blood pressure reduction.

Mechanism of Action

How Indap Works — Mechanism of Action

Indap's action is defined by two primary mechanistic domains: one affecting the kidney and one affecting the peripheral vasculature.

Na^+/ Cl^- Cotransporter Inhibition and Renal Electrolyte Modulation

This domain focuses on Indap's primary biological target: the Sodium-Chloride Cotransporter (NCC or SLC12A3) located in the Distal Convoluted Tubule ( DCT) of the kidney. By inhibiting this transporter, Indap blocks the reabsorption of sodium ( Na^+) and chloride ( Cl^-) ions. This molecular action leads to increased Na^+ and water excretion, resulting in natriuresis and diuresis (increased urine output), which consequently drives the decrease in circulating plasma volume.

Action on Vascular Tone and Peripheral Resistance

The second key domain involves an action on the blood vessel walls, distinct from the primary diuretic mechanism. It acts as a modulator of vascular smooth muscle activity, primarily by affecting the handling of calcium ions ( Ca^2+). This mechanism reduces the contractile tone of the blood vessel musculature. The resulting physiological effect is a reduction in Total Peripheral Resistance ( TPR), which determines the resistance encountered by the heart's systolic output.


The integration of reduced plasma volume and decreased vascular resistance culminates in the resultant hemodynamic changes.

Dosage and Administration Information

Administration Guidelines for Indapamide

Indapamide is administered exclusively via the oral route in tablet form, available as immediate-release (IR) formulations at strengths such as 1.25 mg and 2.5 mg, and as a prolonged-release (PR) tablet, typically 1.5 mg.


Dosing and Schedule

The medication is structured for once-daily use, taken preferably in the morning. This schedule is intended to maintain consistent medicine levels while aligning with the patient's daily cycle to reduce nocturnal urination.

Standard dosing starts low and follows indication-specific titration rules. For the long-term management of high blood pressure, the typical starting dose is 1.25 mg or 1.5 mg PR, with dose adjustments considered at intervals of four weeks. For managing fluid retention (edema), the starting dose is often 2.5 mg, and titration may occur after one week if needed. The maximum labeled daily dose for either condition is typically 5 mg.


Administration Specifics

Indapamide can be taken with or without food. Administration requires that the tablets be swallowed whole with water. This is especially important for the prolonged-release tablets, which must not be crushed or chewed to preserve the controlled release of the active ingredient.

Dosing instructions require a cautious approach for older adults, often beginning at the lowest available dose. The safety and efficacy of Indapamide have not been established for use in pediatric patients.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Indapamide


Evidence for Use in Essential Hypertension (High Blood Pressure)

The research exploring Indapamide for sustained high blood pressure includes large Randomized Controlled Trials (RCTs). These studies were designed to examine the drug’s use both alone and as part of a combination regimen. Researchers monitored changes in blood pressure, specifically Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP). The trials also explored changes in markers that reflect physiological strain, such as the Left Ventricular Mass Index (LVMI).

Studies reported measurements of blood pressure changes observed across various adult populations, including the very elderly (age 80 and over). However, large-scale, long-term trials directly comparing Indapamide monotherapy against all other major classes of blood pressure medications for hard outcomes remain limited.


Evidence for Cardiovascular Risk Management

Research has explored Indapamide in patients who are at high cardiovascular risk. This evidence base consists of large, event-driven, long-term RCTs that monitored outcomes over several years, often using Indapamide as a component of a combination therapy.

Researchers closely monitored the occurrence of major events, including fatal and non-fatal stroke, myocardial infarction, and the development or worsening of heart failure. The studies described patterns regarding the occurrence of these serious health outcomes in high-risk patients, such as those with previous stroke or Type 2 Diabetes Mellitus.

Data for Indapamide used alone in these critical outcome domains remain insufficient, as most definitive findings describe patterns related to the combination therapy.


Key Limitations and Areas of Research Uncertainty

A key limitation is the reliance on combination therapy data for most definitive findings regarding major outcomes. Furthermore, some research focuses on surrogate endpoints, such as microalbuminuria (monitored in diabetes studies) or LVMI, rather than direct long-term outcomes like mortality or kidney failure. These markers are surrogate endpoints; the research provides context but not individual predictions regarding long-term health outcomes. Follow-up durations were limited in some studies, meaning that the durability of the findings over multiple decades is not fully established.

Frequently Asked Questions (FAQ)

Common questions about Indap (FAQ)


Q: How long does it typically take for Indap to start having an effect?

Official documents indicate that the drug reaches its highest concentration in the blood within approximately 1 to 2 hours after taking a tablet. However, the maximal reduction in blood pressure, or the full therapeutic effect, may only be achieved after several months of continuous use.


Q: Does Indap cause weight gain or weight loss?

As a diuretic, Indap works by increasing water and salt loss, which may result in a decrease in fluid-related weight. Official product information notes that rapid or excessive weight loss is a symptom that, according to regulatory notes, requires consultation with a healthcare professional.


Q: Are there any specific foods or drinks to avoid while using Indap?

Official administration guidelines state that Indap is generally unaffected by food and can be taken with or without a meal. However, for people following a salt-restricted diet, the body’s mineral levels (electrolytes) may be monitored due to the drug’s potential effect on fluid balance.


Q: Is Indap considered a 'strong' blood pressure medication?

Studies and official information indicate that Indap is effective in lowering high blood pressure and reducing total peripheral resistance. Its efficacy has been supported by clinical trials in essential hypertension, sometimes when used alone, and sometimes alongside other blood pressure-lowering medicines.


Q: Is Indap known to cause problems with sleeping?

Problems with sleeping are not listed among the common side effects for this drug. However, adverse reactions like nervousness or agitation, which have been reported in post-marketing experience, could potentially affect a person’s sleep patterns.


Q: Does taking Indap affect cholesterol readings?

Official drug information suggests that Indap generally does not appear to change lipid metabolism. This means that studies have found it usually does not alter blood levels of triglycerides, LDL-cholesterol, or HDL-cholesterol.


Q: Is there a maximum amount of time Indap can be taken?

Indap is indicated for the long-term management of hypertension, which is a chronic condition. Official regulatory labeling does not specify a maximum duration for how long the drug can be taken.


Q: Will I need to change my diet while I am taking Indap?

While the drug does not usually require specific food restrictions, monitoring of fluid balance and electrolytes is noted for patients who are already on a salt-restricted diet. This is because the drug's action on fluid balance can increase the body's sensitivity to electrolyte changes.


Q: Can men taking Indap experience sexual side effects?

Official adverse reaction data indicates that decreased sexual ability or impotence has been reported as a potential side effect. This type of effect is sometimes observed with medications that are used to manage blood pressure.


Q: Does Indap increase sensitivity to sunlight?

According to the official adverse reaction data, there have been reports of increased skin sensitivity to sunlight, a condition known as photosensitivity.


Q: Why might a doctor switch me from another diuretic to Indap?

Indapamide is noted for a dual mechanism of action, which is a key differentiating property from some other diuretics. This means it works both by reducing excess fluid and by directly relaxing the walls of the blood vessels to lower resistance.


Q: What is the risk of dehydration when taking Indap?

Indapamide works by increasing the loss of water and electrolytes from the body. Official warnings note that signs of dehydration, such as unusual weakness, increased thirst, or dry mouth, have been noted as a potential risk.


Q: What should I know about Indap before starting to drive or operate machinery?

Official patient guidance notes that this drug may cause side effects such as drowsiness or dizziness. Regulatory information states that individuals should understand how they are affected by the medication before driving or operating machinery.


Q: If my blood pressure is controlled, do I still need to take Indap?

Indap is described as a medication that controls high blood pressure, not one that cures the condition. Official documents state that continued use is standard practice for chronic management unless a healthcare professional adjusts the treatment plan.


Q: Does Indap have different effects on men versus women?

Regulatory data has noted a difference in the risk profile for some electrolyte problems. Specifically, severe cases of low sodium (hyponatremia) have been reported primarily in elderly females, suggesting a potential population difference in risk for this specific side effect.


Q: Is it okay to stop taking Indap suddenly?

Official patient guidance states that changes to treatment, including stopping the medication, should only be made after consulting with a healthcare professional.


Q: What if I take Indap and have a pre-existing low magnesium level?

Official safety warnings indicate that this class of diuretic medicine can increase the body's excretion of magnesium through the urine. This action may result in low magnesium levels, a condition known as hypomagnesemia.


Q: How does Indap compare to common ACE inhibitors (high-level question)?

Indapamide is a diuretic that works by affecting fluid volume and blood vessel tone. In contrast, ACE inhibitors work primarily by blocking the production of a hormone that narrows the blood vessels. Official information notes that these two drug classes are often combined for improved blood pressure control.


Q: Can Indap cause changes in mood or anxiety?

Adverse events like anxiety or nervousness have been reported in official documents. Furthermore, severe fluid and electrolyte imbalances (like low sodium) may cause symptoms that include mood changes or confusion.


Q: What is the general guidance on alcohol consumption while taking Indap?

Official safety information states that alcohol may have additive effects in lowering blood pressure when taken with Indapamide. This combination can increase the risk of side effects like lightheadedness, dizziness, or fainting.

How should Indap be stored and disposed of?

How to Store and Dispose of Indapamide

Indapamide must be stored under specific conditions to ensure product stability, as mandated by regulatory labeling.


Storage Requirements

Classification Official Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Keep away from excessive heat and keep from freezing.
Protection Store in a dry place and away from moisture. Do not store in the bathroom.
Container Keep the medicine in its original container with the cap tightly closed.
Child Safety Keep this medication out of the sight and reach of children.

Disposal Instructions

Do not flush unused Indapamide down a sink or toilet. The medicine should be disposed of through a community drug take-back program or by following the FDA's household disposal procedure. This involves mixing the tablets with an undesirable substance (such as dirt or used coffee grounds) and sealing the mixture in a plastic bag before discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Indap found in:

A-Z Index: